Stein Scott, Lao Yanbin, Yang In-Young, Hecht Stephen S, Moriya Masaaki
Laboratory of Chemical Biology, Department of Pharmacological Sciences, State University of New York, Stony Brook, NY 11794, USA.
Mutat Res. 2006 Sep 19;608(1):1-7. doi: 10.1016/j.mrgentox.2006.01.009. Epub 2006 Jun 21.
Reaction of crotonaldehyde or two molecules of acetaldehyde with DNA generates 3-(2'-deoxyribos-1'-yl)-5,6,7,8-tetrahydro-8-hydroxy-6-methylpyrimido[1,2-a]purine-10(3H)one (2, Scheme 1), which occurs in (6R, 8R) and (6S, 8S) configurations (Fig. 1). These diastereomers were site-specifically incorporated into oligonucleotides, which were then inserted into a double-stranded DNA vector for genotoxicity studies. Modified DNA was introduced into human xeroderma pigmentosum A (XPA) cells to allow replication. Analysis of progeny plasmid revealed that these DNA adducts inhibit DNA synthesis to similar degrees. (6S, 8S)-2 miscodes more frequently than (6R, 8R)-2: 10% versus 5%. For both adducts, major miscoding events were G-->T transversions, but G-->A transitions were also observed at a comparable level for (6R, 8R)-2. G-->C transversions were the second most common events for (6S, 8S)-2. Comparison of these results with those of other 1,N2-propanodeoxyguanosine (PdG) adducts, which were evaluated by the same system, indicates that (i) their synthesis inhibiting potencies are stronger than that of the unsubstituted analog, 3-(2'-deoxyribos-1'-yl)-5,6,7,8-tetrahydro-8-hydroxypyrimido[1,2-a]purine-10(3H)one (1, Scheme 1), but weaker than that of 3-(2'-deoxyribos-1'-yl)-5,6,7,8-tetrahydro-6-hydroxypyrimido[1,2-a]purine-10(3H)one (3, Scheme 1); (ii) both isomers of 2 are more miscoding than 1; (iii) the miscoding potency of (6S, 8S)-2 is comparable to those of 3 and a model PdG 4 lacking a hydroxyl and a methyl group (Fig. 1). Therefore, considering the fact that 2 are formed endogenously as well as exogenously, they may play a significant role in aging and cancer in humans.
巴豆醛或两分子乙醛与DNA反应生成3-(2'-脱氧核糖-1'-基)-5,6,7,8-四氢-8-羟基-6-甲基嘧啶并[1,2-a]嘌呤-10(3H)酮(2,方案1),其以(6R, 8R)和(6S, 8S)构型存在(图1)。这些非对映异构体被位点特异性地掺入寡核苷酸中,然后将其插入双链DNA载体中进行遗传毒性研究。将修饰的DNA导入人着色性干皮病A(XPA)细胞中以进行复制。对后代质粒的分析表明,这些DNA加合物对DNA合成的抑制程度相似。(6S, 8S)-2比(6R, 8R)-2更频繁地发生错配:分别为10%和5%。对于这两种加合物,主要的错配事件是G→T颠换,但对于(6R, 8R)-2,G→A转换也在相当的水平上被观察到。G→C颠换是(6S, 8S)-2的第二常见事件。将这些结果与通过相同系统评估的其他1,N2-丙基脱氧鸟苷(PdG)加合物的结果进行比较,表明(i)它们的合成抑制能力比未取代的类似物3-(2'-脱氧核糖-1'-基)-5,6,7,8-四氢-8-羟基嘧啶并[1,2-a]嘌呤-10(3H)酮(1,方案1)更强,但比3-(2'-脱氧核糖-1'-基)-5,6,7,8-四氢-6-羟基嘧啶并[1,2-a]嘌呤-10(3H)酮(3,方案1)弱;(ii) 2的两种异构体都比1更易发生错配;(iii) (6S, 8S)-2的错配能力与3和一个缺少羟基和甲基的模型PdG 4相当(图1)。因此,考虑到2可内源性和外源性形成这一事实,它们可能在人类衰老和癌症中起重要作用。